Email
IZ Express #1,628: Ask the Experts Hep B updated with new recommendations, and more
| From | Immunize.org <[email protected]> |
| Subject | IZ Express #1,628: Ask the Experts Hep B updated with new recommendations, and more |
| Date | April 20, 2022 10:00 AM |
Links have been removed from this email. Learn more in the FAQ.
Links have been removed from this email. Learn more in the FAQ.
[link removed] [link removed] [link removed] [link removed] [link removed]
Email not displaying correctly? View it in your browser. ([link removed])
[link removed]
Issue 1,628: April 20, 2022
Top Stories
* “Ask the Experts: Hepatitis B” web page updated with new recommendation for universal vaccination of adults through age 59 and added information about PreHevbrio vaccine
* Today! Watch April 20 ACIP meeting.
* National Infant Immunization Week starts April 24! Prepare using CDC’s 2022 digital media toolkit.
* Influenza Vaccination Honor Roll for mandatory healthcare worker vaccination now features 1,282 organizations, including six new hospitals, one long-term care facility, and a large outpatient clinic network
* Influenza activity increases yet again nationally; continue to vaccinate
* Spotlight: Review of resources at Immunize.org that focus on vaccine products and manufacturers
* Vaccines in the news
Vaccine Information Statements
* Reminder! Haitian Creole and Portuguese translations of 18 Vaccine Information Statements posted by Immunize.org.
Featured Resources
* CHOP’s Vaccine Education Center releases “Communicating about Vaccines – COVID-19 and More,” a free, web-based interactive module; CE available
* Order today! Laminated versions of CDC’s 2022 immunization schedules available while supplies last.
* Organizing a new vaccination program? Use Immunize.org’s Vaccinating Adults: A Step-by-Step Guide—free to download by chapter or in its entirety.
Notable Publications
* “Effectiveness of COVID-19 mRNA Vaccination in Preventing COVID-19-Associated Hospitalization among Adults with Previous SARS-CoV-2 Infection—United States, June 2021–February 2022” published in MMWR
* “Supporting Immunization Programs to Address COVID-19 Vaccine Hesitancy: Recommendations for National and Community-Based Stakeholders” published in Vaccine
* “Become a Vaccine Champion” published by American Federation of Teachers
Global News
* “Surveillance to Track Progress toward Polio Eradication—Worldwide, 2020–2021” published in MMWR
* “One-Dose Human Papillomavirus (HPV) Vaccine Offers Solid Protection against Cervical Cancer” published by WHO
Upcoming Events
* Tomorrow! Virtual: Immunize Colorado hosts webinar “For Mothers, by Mothers: A Community Health Meetup That Supports Vaccine Confidence” on April 21.
* Virtual: International Vaccine Access Center hosts webinars on April 26, 28, and May 3 for World Immunization Week
* In person: Register today! National Conference for Immunization Coalitions and Partnerships to be held September 13–15, 2022, in Minneapolis, MN.
Editorial Information
------------------------------------------------------------
Top Stories
------------------------------------------------------------
“Ask the Experts: Hepatitis B” web page updated with new recommendation for universal vaccination of adults through age 59 and added information about PreHevbrio vaccine
Immunize.org updated its popular Ask the Experts: Hepatitis B ([link removed]) web page. This extensive list of clinical questions and answers incorporates the new recommendation for universal vaccination of adults through age 59 and adds information about PreHevbrio (manufactured by VBI). PreHevbrio is licensed and recommended as a hepatitis B vaccine option for people age 18 and older. It is administered as a 3-dose series.
[link removed]
Immunize.org's Ask the Experts ([link removed]) main page leads you to 30 distinct web pages on a variety of topics with more than 1,100 common or challenging questions and answers about vaccines and their administration. Immunize.org's team of experts includes Kelly L. Moore, MD, MPH (team lead), Carolyn B. Bridges, MD, FACP, and Iyabode Beysolow, MD, MPH.
Related Links
* Immunize.org: Ask the Experts: Hepatitis B ([link removed]) web page
* Immunize.org: Hepatitis B Facts: Testing and Vaccination ([link removed]) (PDF)
* Immunize.org: Hepatitis A and Hepatitis B Vaccines: Be Sure Your Patients Get the Correct Dose ([link removed]) (PDF)
* Immunize.org: Standing Orders for Administering Hepatitis B Vaccine to Adults ([link removed]) (PDF)
* Immunize.org: Ask the Experts ([link removed]) main page to answer more than 1,100 questions
------------------------------------------------------------
Today! Watch April 20 ACIP meeting.
CDC will convene its Advisory Committee on Immunization Practices ([link removed]) (ACIP) today, April 20, from 11:00 a.m.–4:00 p.m. (ET).
[link removed]
No registration is required to watch webcasts of live ACIP meetings or listen via telephone. Opportunities for public comment are described at the website.
Related Links
* ACIP main page ([link removed]) for access to webcast and agenda
* ACIP Meeting Information ([link removed]) for presentation slides, content from previous meetings, and information about future meetings
------------------------------------------------------------
National Infant Immunization Week starts April 24! Prepare using CDC’s 2022 digital media toolkit.
National Infant Immunization Week (NIIW) ([link removed]) , April 24–30, highlights the importance of protecting infants from vaccine-preventable diseases and celebrates the achievements of immunization partners. This year, it’s particularly critical to ensure that families get back on track for routine checkups and recommended vaccinations following disruptions from the COVID-19 pandemic.
[link removed]
A CDC report ([link removed]) released in May 2020 found a troubling drop in routine childhood vaccination as a result of families missing many in-person clinical visits during the pandemic: many children remain behind schedule.
Save time by using CDC's 2022 NIIW Digital Media Toolkit ([link removed]) for your organization's NIIW activities. The toolkit includes updated logos, sample social media content, social graphics, and key messages. Please share them, using the hashtags #NIIW and #ivax2protect.
Related Links
* CDC: National Infant Immunization Week ([link removed]) main page
* CDC: 2022 NIIW Digital Media Toolkit ([link removed]) main page
* Immunize.org: Parent Handouts ([link removed]) main page
------------------------------------------------------------
Influenza Vaccination Honor Roll for mandatory healthcare worker vaccination now features 1,282 organizations, including six new hospitals, one long-term care facility, and a large outpatient clinic network
Immunize.org's Influenza Vaccination Honor Roll ([link removed]) recognizes facilities that take a stand for patient safety by implementing policies for mandatory healthcare personnel influenza vaccination. There are now 1,282 healthcare organizations enrolled. Since December 8, 2021, six new hospitals, one long-term care facility, and a large network of outpatient medical practices have been added to the honor roll.
Newly added hospitals and health systems
* CarePoint Health – Bayonne Medical Center, Bayonne, NJ
* CarePoint Health – Hoboken University Medical Center, Hoboken, NJ
* Bronson Commons, Mattawan, MI
* Bronson LakeView Hospital, Paw Paw, MI
* Bronson Battle Creek Hospital, Battle Creek, MI
* Bronson South Haven Hospital, South Haven, MI
Newly added long-term care/assisted living facility
* Bronson Commons, Mattawan MI
Newly added medical practices
* Bronson Health Group Medical Practices, Specialties and Diagnostics
+ (9 clinics) Battle Creek, MI
+ (4 clinics) Marshall, MI
+ (26 clinics) Paw Paw, MI
+ (59 clinics) Kalamazoo, MI
+ (4 clinics) Oshtemo, MI
+ (8 clinics) Portage, MI
+ (3 clinics) Vicksburg, MI
* Bronson LakeView Family Care, Bangor, MI
* Bronson Family Medicine – Blue Star, South Haven, MI
* Bronson LakeView Family Care, Decatur, MI
* Bronson Primary Care Partners, Three Rivers, MI
* Bronson Primary Care Partners, Galesburg MI
* Bronson Primary Care Partners, Richland, MI
[link removed]
Eligibility:
* Eligible organizations: Hospitals, long-term care facilities, medical practices, pharmacies, professional organizations, health departments, and other government entities
* Requirements:
+ Your policy must require influenza vaccination for all staff
+ The application ([link removed]) must describe measures to prevent transmission of influenza from unvaccinated personnel to patients (e.g., masking for the entire work shift)
Related Links
* Immunize.org: List of Influenza Vaccination Honorees, all healthcare settings ([link removed]) , by state
* Immunize.org: Long-Term Care/Assisted Living Influenza Vaccination Honorees ([link removed]) by state
* Immunize.org: Influenza Vaccination Honor Roll program ([link removed]) , including:
+ Position statements ([link removed]) from professional societies and leading healthcare organizations in support of mandatory influenza vaccination
+ Application form for Influenza Vaccination Honor Roll ([link removed])
* Immunize.org: Honor Roll for Patient Safety ([link removed]) web page
------------------------------------------------------------
Influenza activity increases yet again nationally; continue to vaccinate
Influenza Surveillance
For week 14, ending on April 9, Weekly U.S. Influenza Surveillance Report, FluView ([link removed]) summary reports that influenza activity increased in most regions this week, with the highest activity in the central and south-central regions of the country.
[link removed]
Influenza Vaccination Dashboard
CDC's new Weekly Flu Vaccination Dashboard ([link removed]) shares preliminary vaccination data. This week’s key fact: for children 6 months through 17 years, coverage varies widely among states and DC as of March 19, 2022, ranging from 32.4% to 76.5%; overall national coverage is 54.7%.
CDC recommends everyone age 6 months and older get an annual influenza vaccine. Influenza and COVID-19 vaccines may be given at the same visit, if needed. COVID-19 vaccination alone provides no protection from influenza or any other respiratory virus.
Vaccine Finder
If you don’t provide influenza vaccine at your site, please strongly recommend vaccination and refer people to sites that do vaccinate. Use VaccineFinder, a user-friendly website to help people of all ages find influenza, COVID-19, and other vaccines ([link removed]) . Participating providers can update their vaccine inventory estimates on VaccineFinder. For questions or more information, contact [email protected] (mailto:[email protected]) .
Related Links
* CDC: Weekly Flu Vaccination Dashboard ([link removed]) main page
* CDC: FluView ([link removed]) main page
* CDC: Influenza (Flu) ([link removed]) main page
* Immunize.org: free educational materials and patient handouts related to influenza ([link removed])
* Immunize.org: Vaccines: Influenza ([link removed]) main page
* Immunize.org: Ask the Experts: Influenza ([link removed]) main page
* VaccineFinder ([link removed]) website
* Families Fighting Flu: Flu Resources for Healthcare Professionals ([link removed]) main page
------------------------------------------------------------
Spotlight: Review of resources at Immunize.org that focus on vaccine products and manufacturers
In this week's Spotlight, we summarize resources at Immunize.org that focus on specific vaccine products.
Package Inserts and FDA Product Approvals main page ([link removed]) provides up-to-date product information links for all vaccines licensed for use in the United States, as well as links to FDA vaccine approval web pages.
Vaccine Manufacturers main ([link removed]) page provides links to the websites of the vaccine manufacturers in the United States, as well as contact information such as telephone numbers and email addresses. In addition, the vaccine products for each of the companies are listed.
Vaccines main page ([link removed]) links to information about 23 vaccines and the diseases they prevent. For each vaccine, access the latest recommendations, information, and up-to-date resources from Immunize.org and CDC.
------------------------------------------------------------
Vaccines in the news
These recent articles convey the potential risks of vaccine-preventable diseases and the importance of vaccination.
* NEJM: COVID-19 Boosters—Where from Here? ([link removed]) (4/13/22)
* Washington Post: Pandemic Led to Fewer Adolescents Vaccinated against HPV, CDC Says ([link removed]) (4/12/22)
* Science: Pandemic Propels Global Effort to Study Rare Vaccine Side Effects ([link removed]) (4/12/22)
* Nature: COVID-19 Vaccine Hesitancy ([link removed]) (4/12/22)
* Wall Street Journal: COVID-19 Vaccines Carry Low Risk of Heart Conditions, Studies Find ([link removed]) (4/11/22)
* Washington Post: White House Tells Agencies to Delay Vaccine Mandate after Court Win ([link removed]) (4/8/22)
* JAMA: Medicare Coverage of Vaccines—A Work in Progress ([link removed]) (4/4/22)
------------------------------------------------------------
Vaccine Information Statements
------------------------------------------------------------
Reminder! Haitian Creole and Portuguese translations of 18 Vaccine Information Statements posted by Immunize.org.
Immunize.org posted new translations of 18 Vaccine Information Statements (VISs) ([link removed]) in Haitian Creole ([link removed]) and Portuguese ([link removed]) . These translations were generously donated by the Massachusetts Department of Public Health Immunization Program.
All translations are available in print-ready PDF format.
VIS translations in Haitian Creole ([link removed]) :
* Diphtheria, tetanus, pertussis (DTaP) VIS PDF ([link removed]) (view in English ([link removed]) )
* Haemophilus influenzae type b (Hib) VIS PDF ([link removed]) (view in English ([link removed]) )
* Hepatitis A VIS PDF ([link removed]) (view in English ([link removed]) )
* Hepatitis B VIS PDF ([link removed]) (view in English ([link removed]) )
* HPV (human papillomavirus) VIS PDF ([link removed]) (view in English ([link removed]) )
* Influenza, inactivated or recombinant VIS PDF ([link removed]) (view in English ([link removed]) )
* Influenza, live intranasal VIS PDF ([link removed]) (view in English ([link removed]) )
* Measles, mumps, rubella (MMR) VIS PDF ([link removed]) (view in English ([link removed]) )
* Measles, mumps, rubella, varicella (MMRV) VIS PDF ([link removed]) (view in English ([link removed]) )
* Meningococcal ACWY VIS PDF ([link removed]) (view in English ([link removed]) )
* Meningococcal B VIS PDF ([link removed]) (view in English ([link removed]) )
* Pneumococcal conjugate (PCV) VIS PDF ([link removed]) (view in English ([link removed]) )
* Polio VIS PDF ([link removed]) (view in English ([link removed]) )
* Rotavirus VIS PDF ([link removed]) (view in English ([link removed]) )
* Tetanus, diphtheria (Td) VIS PDF ([link removed]) (view in English ([link removed]) )
* Tetanus, diphtheria, pertussis (Tdap) VIS PDF ([link removed]) (view in English ([link removed]) )
* Varicella (chickenpox) VIS PDF ([link removed]) (view in English ([link removed]) )
* Recombinant zoster (shingles) VIS PDF ([link removed]) (view in English ([link removed]) )
VIS translations in Portuguese ([link removed]) :
* Diphtheria, tetanus, pertussis (DTaP) VIS PDF ([link removed]) (view in English ([link removed]) )
* Haemophilus influenzae type b (Hib) VIS PDF ([link removed]) (view in English ([link removed]) )
* Hepatitis A VIS PDF ([link removed]) (view in English ([link removed]) )
* Hepatitis B VIS PDF ([link removed]) (view in English ([link removed]) )
* HPV (human papillomavirus) VIS PDF ([link removed]) (view in English ([link removed]) )
* Influenza, inactivated or recombinant VIS PDF ([link removed]) (view in English ([link removed]) )
* Influenza, live intranasal VIS PDF ([link removed]) (view in English ([link removed]) )
* Measles, mumps, rubella (MMR) VIS PDF ([link removed]) (view in English ([link removed]) )
* Measles, mumps, rubella, varicella (MMRV) VIS PDF ([link removed]) (view in English ([link removed]) )
* Meningococcal ACWY VIS PDF ([link removed]) (view in English ([link removed]) )
* Meningococcal B VIS PDF ([link removed]) (view in English ([link removed]) )
* Pneumococcal conjugate (PCV) VIS PDF ([link removed]) (view in English ([link removed]) )
* Polio VIS PDF ([link removed]) (view in English ([link removed]) )
* Rotavirus VIS PDF ([link removed]) (view in English ([link removed]) )
* Tetanus, diphtheria (Td) VIS PDF ([link removed]) (view in English ([link removed]) )
* Tetanus, diphtheria, pertussis (Tdap) VIS PDF ([link removed]) (view in English ([link removed]) )
* Varicella (chickenpox) VIS PDF ([link removed]) (view in English ([link removed]) )
* Recombinant zoster (shingles) VIS PDF ([link removed]) (view in English ([link removed]) )
Translations of previous VIS versions may be used until new translations become available. CDC states that the corresponding up-to-date English-language VIS must also be supplied when providing an out-of-date translation.
Related Links
* Immunize.org: Vaccine Information Statement ([link removed]) main page for VISs in 46 languages ([link removed])
* Immunize.org: Dates of Current Vaccine Information Statements ([link removed]) (PDF)
* CDC: What's New with VISs ([link removed]) web page
* CDC: Current VISs ([link removed]) web page
------------------------------------------------------------
Featured Resources
------------------------------------------------------------
CHOP’s Vaccine Education Center releases “Communicating about Vaccines – COVID-19 and More,” a free, web-based interactive module; CE available
Children’s Hospital of Philadelphia’s (CHOP) Vaccine Education Center (VEC) released Communicating about Vaccines – COVID-19 and More ([link removed]) , a free, web-based interactive session. It is divided into three parts:
* Part 1: Details the dangers of COVID-19 disease, explains the U.S. system to authorize and license vaccines, and highlights the safety and effectiveness of COVID-19 vaccines
* Part 2: Explores best practices in vaccine communication
* Part 3: Reviews key points, offers additional resources, and explains how to receive continuing education credit (up to 2 hours) or a certificate of attendance
To access versions “for credit” (registration required) or “no credit,” visit Online Learning for Healthcare Providers ([link removed]) web page.
[link removed]
This module was developed by the Vaccine Education Center ([link removed]) and the Office of Community Engagement at CHOP, in partnership with the Pennsylvania Chapter of the American Academy of Pediatrics, Pennsylvania Immunization Coalition, and Philadelphia Department of Public Health.
------------------------------------------------------------
Order today! Laminated versions of CDC’s 2022 immunization schedules available while supplies last.
Immunize.org's laminated versions of the 2022 U.S. child and adolescent immunization schedule ([link removed]) and the 2022 U.S. adult immunization schedule ([link removed]) are in stock and shipping now. Order while supplies last.
While the schedules are available online from CDC at no cost, Immunize.org's printed, laminated schedules are ideal for use in any busy healthcare setting where vaccinations are given. Their tough coating can be wiped down, and they’re durable enough to stand up to a year's worth of use.
In 2022, the length of each schedule with appendices was extended by two pages. As a result, the laminated schedules are now published in a standard 8.5” X 11” booklet format.
* The child/adolescent schedule booklet is ten pages (i.e., five double-sided pages) and includes a bonus page with Immunize.org’s popular 1-page handout summarizing the dose, route, and needle size recommendations for all vaccines and recipients
* The adult schedule booklet is eight pages (i.e., four double-sided pages)
[link removed]
With color coding for easy reading, our laminated schedules replicate the original CDC formatting, including the essential tables and notes.
PRICING
Number of Copies Cost
1–4 copies $7.50 each
5–19 copies $5.50 each
20–99 copies $4.50 each
100–499 copies $4.00 each
500–999 copies $3.50 each
For quotes on customizing or placing orders of 1,000 copies or more, call 651-647-9009 or email [email protected].
Visit the Shop Immunize.org: Laminated Schedules ([link removed]) web page for more information on the schedules, to view images of all the pages, to download the order form, and to order today!
Related Links
* Immunize.org: Laminated Child and Adolescent Immunization Schedules (0–18 years) ([link removed]) web page
* Immunize.org: Laminated Adult Immunization Schedules (19 and older) ([link removed]) web page
* Immunize.org: Shop Immunize.org ([link removed]) main page
------------------------------------------------------------
Organizing a new vaccination program? Use Immunize.org’s Vaccinating Adults: A Step-by-Step Guide—free to download by chapter or in its entirety.
Download Immunize.org’s free 142-page book on adult vaccination, to help build your program and train your team: Vaccinating Adults: A Step-by-Step Guide (Guide) ([link removed]) .
[link removed]
This thorough "how to" guide on adult vaccination provides easy-to-use, practical information covering all essential activities. It helps vaccine providers enhance their existing adult vaccination services or introduce them into any clinical setting.
The Guide is available to download/print either by chapter or in its entirety free at www.immunize.org/guide ([link removed]) . The National Vaccine Program Office and CDC both supported the development of the Guide and provided early technical review.
The Guide is a valuable resource to assist providers in increasing adult vaccination rates. Be sure to get a copy today!
Please note: this guide was produced in 2017, before the COVID-19 era, and reflects the recommendations of that time.
Related Links
* Vaccinating Adults: A Step-by-Step Guide ([link removed]) main page, permitting download of entire Guide (142 pages, PDF) ([link removed])
* View the table of contents and individual chapters (PDF):
+ Table of Contents ([link removed])
+ Step 1: Getting Started ([link removed])
+ Step 2: Setting Up for Vaccination Services ([link removed])
+ Step 3: Vaccine Storage and Handling ([link removed])
+ Step 4: Deciding Whom to Vaccinate ([link removed])
+ Step 5: Administering Vaccines ([link removed])
+ Step 6: Documentation and Related Issues ([link removed])
+ Step 7A: Financial Considerations ([link removed])
+ Step 7B: How to Bill for Adult Immunizations ([link removed])
* Immunize.org’s educational materials (handouts) on adult immunization ([link removed])
------------------------------------------------------------
Notable Publications
------------------------------------------------------------
“Effectiveness of COVID-19 mRNA Vaccination in Preventing COVID-19-Associated Hospitalization among Adults with Previous SARS-CoV-2 Infection—United States, June 2021–February 2022” published in MMWR
CDC published Effectiveness of COVID-19 mRNA Vaccination in Preventing COVID-19-Associated Hospitalization among Adults with Previous SARS-CoV-2 Infection—United States, June 2021–February 2022 ([link removed]) in MMWR. A portion of the summary appears below.
Persons with previous SARS-CoV-2 infection have some protection against reinfection leading to hospitalization, but there is limited evidence regarding the additional benefit of vaccination among these persons....
Among persons with previous infection, COVID-19 mRNA vaccination provided protection against subsequent COVID-19–associated hospitalization. Estimated vaccine effectiveness against reinfection leading to hospitalization during the Omicron-predominant period was approximately 35% after dose 2, and 68% after a booster dose....
To prevent COVID-19–associated hospitalization, all eligible persons should stay up to date with vaccination, including those with previous SARS-CoV-2 infection.
Access the MMWR article in HTML ([link removed]) or PDF ([link removed]) .
Related Link
* MMWR's main page ([link removed]) provides access to MMWR Weekly and its companion publications
------------------------------------------------------------
“Supporting Immunization Programs to Address COVID-19 Vaccine Hesitancy: Recommendations for National and Community-Based Stakeholders” published in Vaccine
In its March 28 issue, Vaccine published Supporting Immunization Programs to Address COVID-19 Vaccine Hesitancy: Recommendations for National and Community-Based Stakeholders ([link removed]) . The article is a collaborative effort of the Association of Immunization Managers, with lead author Katelyn Wells, MS, PhD, Immunize.org's Kelly L. Moore, MD, MPH, and Emory University’s Robert Bednarczyk, PhD. The conclusion appears below.
The 64 state, local and territorial IPs [immunization programs] are the backbone of the US immunization system, so we advocate for engagement of all stakeholders to directly support IPs in addressing vaccine hesitancy within their jurisdictions. To maintain routine vaccination coverage rates and implement a successful COVID-19 vaccination campaign, IPs need engagement of stakeholders at all levels to promote sound immunization policies, identify and address the needs of vulnerable subpopulations, implement evidence-based strategies to promote the value of vaccination, and combat misinformation online. IPs, with support of stakeholders, are the key to effectively addressing the complex challenges of vaccine hesitancy in order to bring the pandemic to a swift end.
------------------------------------------------------------
"Become a Vaccine Champion" published by American Federation of Teachers
The American Federation of Teachers published Become a Vaccine Champion ([link removed]) , written by Immunize.org’s Mary Beth Koslap-Petraco, DNP, FAANP. A portion of the article appears below.
By virtue of our profession, nurses have a head start in championing vaccines for ourselves, our patients, and our communities. Ours is the most trusted of all professions. We are rated highly because we’re seen as honest and ethical. The public trusts that we put our patients’ needs ahead of the interests of others. Our voices are heard and our opinions are respected because of what we do. No matter what field of nursing we practice, we all spend much of our time educating patients. We have a way of speaking that makes complicated material understandable without talking down to patients. We need to use that influence to clarify misinformation about vaccines, reassure each other and the public that the science behind vaccines is solid, and encourage everyone to get vaccinated. I truly believe that every nurse should be a vaccine champion and that every nurse can be a vaccine champion. It all starts with conversations with fellow nurses who may be hesitant about vaccines.
------------------------------------------------------------
Global News
------------------------------------------------------------
“Surveillance to Track Progress toward Polio Eradication—Worldwide, 2020–2021” published in MMWR
CDC published Surveillance to Track Progress toward Polio Eradication—Worldwide, 2020–2021 ([link removed]) on April 15 in MMWR. A portion of the summary appears below.
Acute flaccid paralysis (AFP) surveillance, the primary means of tracking poliovirus transmission, is supplemented by environmental surveillance of sewage samples. The COVID-19 pandemic negatively affected polio surveillance....
Analysis of 2020–2021 AFP surveillance data from 43 priority countries experiencing or at high risk for poliovirus transmission found that national AFP surveillance performance improved from 2020 to 2021 in many priority countries, particularly in the World Health Organization’s African Region; however, substantial national and subnational gaps persist....
Surveillance gaps need to be identified and addressed to ensure timely detection of poliovirus circulation and achieve eventual eradication.
Access the MMWR article in HTML ([link removed]) or PDF ([link removed]) .
Related Links
* MMWR's main page ([link removed]) provides access to MMWR Weekly and its companion publications
* Immunize.org: Vaccines: Polio ([link removed]) main page
* Immunize.org: Ask the Experts: Polio ([link removed]) web page
Back to top (#Top)
------------------------------------------------------------
“One-Dose Human Papillomavirus (HPV) Vaccine Offers Solid Protection against Cervical Cancer” published by WHO
The World Health Organization (WHO) published One-Dose Human Papillomavirus (HPV) Vaccine Offers Solid Protection against Cervical Cancer ([link removed]-(hpv)-vaccine-offers-solid-protection-against-cervical-cancer) on April 11. The recommendations of WHO do not alter the ACIP-recommended schedule for HPV vaccination in the United States.
A portion of the article appears below.
The 4-7 April convening of the WHO Strategic Advisory Group of Experts on Immunization (SAGE) evaluated the evidence that has been emerging over past years that single-dose schedules provide comparable efficacy to the two or three-dose regimens.
SAGE’s review concluded that a single-dose Human Papillomavirus (HPV) vaccine delivers solid protection against HPV, the virus that causes cervical cancer, that is comparable to 2-dose schedules. This could be a game-changer for the prevention of the disease; seeing more doses of the life-saving jab reach more girls....
“The HPV vaccine is highly effective for the prevention of HPV serotypes 16 & 18, which cause 70% of cervical cancer,” said Dr Alejandro Cravioto, SAGE Chair. “SAGE urges all countries to introduce HPV vaccines and prioritize multi-age cohort catch up of missed and older cohorts of girls. These recommendations will enable more girls and women to be vaccinated and thus preventing them from having cervical cancer and all its consequences over the course of their lifetimes.”
SAGE recommended one- or two-dose vaccination schedules for girls and women through age 20 and two doses for women 21 and older. WHO’s recommendations will be updated following further consultation across stakeholders.
Related Links
* SAGE: April 4–7, 2022, meeting highlights ([link removed]) (PDF)
* Immunize.org: Vaccines: Human Papillomavirus (HPV) ([link removed]) main page
* Immunize.org: Ask the Experts: HPV ([link removed]) web page
------------------------------------------------------------
Upcoming Events
------------------------------------------------------------
Tomorrow! Virtual: Immunize Colorado hosts webinar “For Mothers, by Mothers: A Community Health Meetup That Supports Vaccine Confidence” on April 21.
Immunize Colorado ([link removed]) will host a webinar with IDEO.org ([link removed]) and National Resource Center for Refugees, Immigrants, and Migrants ([link removed]) (NRC-RIM) titled For Mothers, by Mothers: A Community Health Meetup That Supports Vaccine Confidence ([link removed]) at 12:00 p.m. (ET) on April 21. The webinar showcases the Mothers X Mothers ([link removed]) initiative, a toolkit designed to help organizations implement health-focused meetups for immigrant and refugee moms. There will also be focus on how organizations can support vaccine confidence in any community.
Register for the webinar ([link removed]) .
This event will be archived on Immunize Colorado's Education Series Past Events ([link removed]) web page.
------------------------------------------------------------
Virtual: International Vaccine Access Center hosts webinars on April 26, 28, and May 3 for World Immunization Week
Johns Hopkins University's International Vaccine Access Center ([link removed]) (IVAC), along with global immunization and indigenous health partners, will host a series of three webinars ([link removed]) to recognize World Immunization Week, April 24 to 30. Registration dates and times are as follows:
* April 26 from 6:00–7:00 p.m. (ET): Enabling Equitable Access to COVID-19 Vaccines for Indigenous Populations ([link removed])
* April 28 from 8:00–9:00 a.m. (ET): The Value of Vaccines across the Life Course: A Showcase of Global Findings ([link removed])
* May 3 from 9:00–10:30 a.m. (ET): The Human Cost of Pneumonia and the Power of the PCV: Stories from Somalia and India ([link removed])
The webinars are free to attend.
------------------------------------------------------------
In person: Register today! National Conference for Immunization Coalitions and Partnerships to be held September 13–15, 2022, in Minneapolis, MN.
Immunize.org and Voices for Vaccines are cosponsoring the 15th National for Immunization Coalitions and Partnerships ([link removed]) (NCICP). This is planned as an in-person meeting in Minneapolis/St. Paul at the Radisson Blu Mall of America ([link removed]) on September 13–15, 2022.
[link removed]
The NCICP is the only conference solely dedicated to collaboration and partnership to improve immunization uptake, educate our communities, and prevent the spread of disease. The conference is an engine to address immunizations and public health challenges by sharing successful strategies that strengthen the work our coalitions and partnerships do.
Register for the event ([link removed]) . Registration fee: $300 (early bird $260 registration available now).
------------------------------------------------------------
For more upcoming events, visit our Calendar of Events ([link removed]) .
Editorial Information
Editor-in-Chief
Kelly L. Moore, MD, MPH
Managing Editor
John D. Grabenstein, RPh, PhD
Associate Editor
Sharon G. Humiston, MD, MPH
Writer/Publication Coordinator
Taryn Chapman, MS
Courtnay Londo, MA
Style and Copy Editor
Marian Deegan, JD
Web Edition Managers
Arkady Shakhnovich
Jermaine Royes
Contributing Writer
Laurel H. Wood, MPA
Technical Reviewer
Robin VanOss
About IZ Express
Immunize.org welcomes redistribution of this issue of IZ Express or selected articles.
When you do so, please add a note that Immunize.org is the source of the material and provide a link to this issue ([link removed] ) .
IZ Express is supported in part by Grant No. 1NH23IP922654 from the National Center for Immunization and Respiratory Diseases, CDC. Its contents are solely the responsibility of Immunize.org and do not necessarily represent the official views of CDC.
IZ Express Disclaimer ([link removed])
ISSN: 2771-8085
==============================================
Unsubscribe [email protected] from this list:
[link removed]
Email not displaying correctly? View it in your browser. ([link removed])
[link removed]
Issue 1,628: April 20, 2022
Top Stories
* “Ask the Experts: Hepatitis B” web page updated with new recommendation for universal vaccination of adults through age 59 and added information about PreHevbrio vaccine
* Today! Watch April 20 ACIP meeting.
* National Infant Immunization Week starts April 24! Prepare using CDC’s 2022 digital media toolkit.
* Influenza Vaccination Honor Roll for mandatory healthcare worker vaccination now features 1,282 organizations, including six new hospitals, one long-term care facility, and a large outpatient clinic network
* Influenza activity increases yet again nationally; continue to vaccinate
* Spotlight: Review of resources at Immunize.org that focus on vaccine products and manufacturers
* Vaccines in the news
Vaccine Information Statements
* Reminder! Haitian Creole and Portuguese translations of 18 Vaccine Information Statements posted by Immunize.org.
Featured Resources
* CHOP’s Vaccine Education Center releases “Communicating about Vaccines – COVID-19 and More,” a free, web-based interactive module; CE available
* Order today! Laminated versions of CDC’s 2022 immunization schedules available while supplies last.
* Organizing a new vaccination program? Use Immunize.org’s Vaccinating Adults: A Step-by-Step Guide—free to download by chapter or in its entirety.
Notable Publications
* “Effectiveness of COVID-19 mRNA Vaccination in Preventing COVID-19-Associated Hospitalization among Adults with Previous SARS-CoV-2 Infection—United States, June 2021–February 2022” published in MMWR
* “Supporting Immunization Programs to Address COVID-19 Vaccine Hesitancy: Recommendations for National and Community-Based Stakeholders” published in Vaccine
* “Become a Vaccine Champion” published by American Federation of Teachers
Global News
* “Surveillance to Track Progress toward Polio Eradication—Worldwide, 2020–2021” published in MMWR
* “One-Dose Human Papillomavirus (HPV) Vaccine Offers Solid Protection against Cervical Cancer” published by WHO
Upcoming Events
* Tomorrow! Virtual: Immunize Colorado hosts webinar “For Mothers, by Mothers: A Community Health Meetup That Supports Vaccine Confidence” on April 21.
* Virtual: International Vaccine Access Center hosts webinars on April 26, 28, and May 3 for World Immunization Week
* In person: Register today! National Conference for Immunization Coalitions and Partnerships to be held September 13–15, 2022, in Minneapolis, MN.
Editorial Information
------------------------------------------------------------
Top Stories
------------------------------------------------------------
“Ask the Experts: Hepatitis B” web page updated with new recommendation for universal vaccination of adults through age 59 and added information about PreHevbrio vaccine
Immunize.org updated its popular Ask the Experts: Hepatitis B ([link removed]) web page. This extensive list of clinical questions and answers incorporates the new recommendation for universal vaccination of adults through age 59 and adds information about PreHevbrio (manufactured by VBI). PreHevbrio is licensed and recommended as a hepatitis B vaccine option for people age 18 and older. It is administered as a 3-dose series.
[link removed]
Immunize.org's Ask the Experts ([link removed]) main page leads you to 30 distinct web pages on a variety of topics with more than 1,100 common or challenging questions and answers about vaccines and their administration. Immunize.org's team of experts includes Kelly L. Moore, MD, MPH (team lead), Carolyn B. Bridges, MD, FACP, and Iyabode Beysolow, MD, MPH.
Related Links
* Immunize.org: Ask the Experts: Hepatitis B ([link removed]) web page
* Immunize.org: Hepatitis B Facts: Testing and Vaccination ([link removed]) (PDF)
* Immunize.org: Hepatitis A and Hepatitis B Vaccines: Be Sure Your Patients Get the Correct Dose ([link removed]) (PDF)
* Immunize.org: Standing Orders for Administering Hepatitis B Vaccine to Adults ([link removed]) (PDF)
* Immunize.org: Ask the Experts ([link removed]) main page to answer more than 1,100 questions
------------------------------------------------------------
Today! Watch April 20 ACIP meeting.
CDC will convene its Advisory Committee on Immunization Practices ([link removed]) (ACIP) today, April 20, from 11:00 a.m.–4:00 p.m. (ET).
[link removed]
No registration is required to watch webcasts of live ACIP meetings or listen via telephone. Opportunities for public comment are described at the website.
Related Links
* ACIP main page ([link removed]) for access to webcast and agenda
* ACIP Meeting Information ([link removed]) for presentation slides, content from previous meetings, and information about future meetings
------------------------------------------------------------
National Infant Immunization Week starts April 24! Prepare using CDC’s 2022 digital media toolkit.
National Infant Immunization Week (NIIW) ([link removed]) , April 24–30, highlights the importance of protecting infants from vaccine-preventable diseases and celebrates the achievements of immunization partners. This year, it’s particularly critical to ensure that families get back on track for routine checkups and recommended vaccinations following disruptions from the COVID-19 pandemic.
[link removed]
A CDC report ([link removed]) released in May 2020 found a troubling drop in routine childhood vaccination as a result of families missing many in-person clinical visits during the pandemic: many children remain behind schedule.
Save time by using CDC's 2022 NIIW Digital Media Toolkit ([link removed]) for your organization's NIIW activities. The toolkit includes updated logos, sample social media content, social graphics, and key messages. Please share them, using the hashtags #NIIW and #ivax2protect.
Related Links
* CDC: National Infant Immunization Week ([link removed]) main page
* CDC: 2022 NIIW Digital Media Toolkit ([link removed]) main page
* Immunize.org: Parent Handouts ([link removed]) main page
------------------------------------------------------------
Influenza Vaccination Honor Roll for mandatory healthcare worker vaccination now features 1,282 organizations, including six new hospitals, one long-term care facility, and a large outpatient clinic network
Immunize.org's Influenza Vaccination Honor Roll ([link removed]) recognizes facilities that take a stand for patient safety by implementing policies for mandatory healthcare personnel influenza vaccination. There are now 1,282 healthcare organizations enrolled. Since December 8, 2021, six new hospitals, one long-term care facility, and a large network of outpatient medical practices have been added to the honor roll.
Newly added hospitals and health systems
* CarePoint Health – Bayonne Medical Center, Bayonne, NJ
* CarePoint Health – Hoboken University Medical Center, Hoboken, NJ
* Bronson Commons, Mattawan, MI
* Bronson LakeView Hospital, Paw Paw, MI
* Bronson Battle Creek Hospital, Battle Creek, MI
* Bronson South Haven Hospital, South Haven, MI
Newly added long-term care/assisted living facility
* Bronson Commons, Mattawan MI
Newly added medical practices
* Bronson Health Group Medical Practices, Specialties and Diagnostics
+ (9 clinics) Battle Creek, MI
+ (4 clinics) Marshall, MI
+ (26 clinics) Paw Paw, MI
+ (59 clinics) Kalamazoo, MI
+ (4 clinics) Oshtemo, MI
+ (8 clinics) Portage, MI
+ (3 clinics) Vicksburg, MI
* Bronson LakeView Family Care, Bangor, MI
* Bronson Family Medicine – Blue Star, South Haven, MI
* Bronson LakeView Family Care, Decatur, MI
* Bronson Primary Care Partners, Three Rivers, MI
* Bronson Primary Care Partners, Galesburg MI
* Bronson Primary Care Partners, Richland, MI
[link removed]
Eligibility:
* Eligible organizations: Hospitals, long-term care facilities, medical practices, pharmacies, professional organizations, health departments, and other government entities
* Requirements:
+ Your policy must require influenza vaccination for all staff
+ The application ([link removed]) must describe measures to prevent transmission of influenza from unvaccinated personnel to patients (e.g., masking for the entire work shift)
Related Links
* Immunize.org: List of Influenza Vaccination Honorees, all healthcare settings ([link removed]) , by state
* Immunize.org: Long-Term Care/Assisted Living Influenza Vaccination Honorees ([link removed]) by state
* Immunize.org: Influenza Vaccination Honor Roll program ([link removed]) , including:
+ Position statements ([link removed]) from professional societies and leading healthcare organizations in support of mandatory influenza vaccination
+ Application form for Influenza Vaccination Honor Roll ([link removed])
* Immunize.org: Honor Roll for Patient Safety ([link removed]) web page
------------------------------------------------------------
Influenza activity increases yet again nationally; continue to vaccinate
Influenza Surveillance
For week 14, ending on April 9, Weekly U.S. Influenza Surveillance Report, FluView ([link removed]) summary reports that influenza activity increased in most regions this week, with the highest activity in the central and south-central regions of the country.
[link removed]
Influenza Vaccination Dashboard
CDC's new Weekly Flu Vaccination Dashboard ([link removed]) shares preliminary vaccination data. This week’s key fact: for children 6 months through 17 years, coverage varies widely among states and DC as of March 19, 2022, ranging from 32.4% to 76.5%; overall national coverage is 54.7%.
CDC recommends everyone age 6 months and older get an annual influenza vaccine. Influenza and COVID-19 vaccines may be given at the same visit, if needed. COVID-19 vaccination alone provides no protection from influenza or any other respiratory virus.
Vaccine Finder
If you don’t provide influenza vaccine at your site, please strongly recommend vaccination and refer people to sites that do vaccinate. Use VaccineFinder, a user-friendly website to help people of all ages find influenza, COVID-19, and other vaccines ([link removed]) . Participating providers can update their vaccine inventory estimates on VaccineFinder. For questions or more information, contact [email protected] (mailto:[email protected]) .
Related Links
* CDC: Weekly Flu Vaccination Dashboard ([link removed]) main page
* CDC: FluView ([link removed]) main page
* CDC: Influenza (Flu) ([link removed]) main page
* Immunize.org: free educational materials and patient handouts related to influenza ([link removed])
* Immunize.org: Vaccines: Influenza ([link removed]) main page
* Immunize.org: Ask the Experts: Influenza ([link removed]) main page
* VaccineFinder ([link removed]) website
* Families Fighting Flu: Flu Resources for Healthcare Professionals ([link removed]) main page
------------------------------------------------------------
Spotlight: Review of resources at Immunize.org that focus on vaccine products and manufacturers
In this week's Spotlight, we summarize resources at Immunize.org that focus on specific vaccine products.
Package Inserts and FDA Product Approvals main page ([link removed]) provides up-to-date product information links for all vaccines licensed for use in the United States, as well as links to FDA vaccine approval web pages.
Vaccine Manufacturers main ([link removed]) page provides links to the websites of the vaccine manufacturers in the United States, as well as contact information such as telephone numbers and email addresses. In addition, the vaccine products for each of the companies are listed.
Vaccines main page ([link removed]) links to information about 23 vaccines and the diseases they prevent. For each vaccine, access the latest recommendations, information, and up-to-date resources from Immunize.org and CDC.
------------------------------------------------------------
Vaccines in the news
These recent articles convey the potential risks of vaccine-preventable diseases and the importance of vaccination.
* NEJM: COVID-19 Boosters—Where from Here? ([link removed]) (4/13/22)
* Washington Post: Pandemic Led to Fewer Adolescents Vaccinated against HPV, CDC Says ([link removed]) (4/12/22)
* Science: Pandemic Propels Global Effort to Study Rare Vaccine Side Effects ([link removed]) (4/12/22)
* Nature: COVID-19 Vaccine Hesitancy ([link removed]) (4/12/22)
* Wall Street Journal: COVID-19 Vaccines Carry Low Risk of Heart Conditions, Studies Find ([link removed]) (4/11/22)
* Washington Post: White House Tells Agencies to Delay Vaccine Mandate after Court Win ([link removed]) (4/8/22)
* JAMA: Medicare Coverage of Vaccines—A Work in Progress ([link removed]) (4/4/22)
------------------------------------------------------------
Vaccine Information Statements
------------------------------------------------------------
Reminder! Haitian Creole and Portuguese translations of 18 Vaccine Information Statements posted by Immunize.org.
Immunize.org posted new translations of 18 Vaccine Information Statements (VISs) ([link removed]) in Haitian Creole ([link removed]) and Portuguese ([link removed]) . These translations were generously donated by the Massachusetts Department of Public Health Immunization Program.
All translations are available in print-ready PDF format.
VIS translations in Haitian Creole ([link removed]) :
* Diphtheria, tetanus, pertussis (DTaP) VIS PDF ([link removed]) (view in English ([link removed]) )
* Haemophilus influenzae type b (Hib) VIS PDF ([link removed]) (view in English ([link removed]) )
* Hepatitis A VIS PDF ([link removed]) (view in English ([link removed]) )
* Hepatitis B VIS PDF ([link removed]) (view in English ([link removed]) )
* HPV (human papillomavirus) VIS PDF ([link removed]) (view in English ([link removed]) )
* Influenza, inactivated or recombinant VIS PDF ([link removed]) (view in English ([link removed]) )
* Influenza, live intranasal VIS PDF ([link removed]) (view in English ([link removed]) )
* Measles, mumps, rubella (MMR) VIS PDF ([link removed]) (view in English ([link removed]) )
* Measles, mumps, rubella, varicella (MMRV) VIS PDF ([link removed]) (view in English ([link removed]) )
* Meningococcal ACWY VIS PDF ([link removed]) (view in English ([link removed]) )
* Meningococcal B VIS PDF ([link removed]) (view in English ([link removed]) )
* Pneumococcal conjugate (PCV) VIS PDF ([link removed]) (view in English ([link removed]) )
* Polio VIS PDF ([link removed]) (view in English ([link removed]) )
* Rotavirus VIS PDF ([link removed]) (view in English ([link removed]) )
* Tetanus, diphtheria (Td) VIS PDF ([link removed]) (view in English ([link removed]) )
* Tetanus, diphtheria, pertussis (Tdap) VIS PDF ([link removed]) (view in English ([link removed]) )
* Varicella (chickenpox) VIS PDF ([link removed]) (view in English ([link removed]) )
* Recombinant zoster (shingles) VIS PDF ([link removed]) (view in English ([link removed]) )
VIS translations in Portuguese ([link removed]) :
* Diphtheria, tetanus, pertussis (DTaP) VIS PDF ([link removed]) (view in English ([link removed]) )
* Haemophilus influenzae type b (Hib) VIS PDF ([link removed]) (view in English ([link removed]) )
* Hepatitis A VIS PDF ([link removed]) (view in English ([link removed]) )
* Hepatitis B VIS PDF ([link removed]) (view in English ([link removed]) )
* HPV (human papillomavirus) VIS PDF ([link removed]) (view in English ([link removed]) )
* Influenza, inactivated or recombinant VIS PDF ([link removed]) (view in English ([link removed]) )
* Influenza, live intranasal VIS PDF ([link removed]) (view in English ([link removed]) )
* Measles, mumps, rubella (MMR) VIS PDF ([link removed]) (view in English ([link removed]) )
* Measles, mumps, rubella, varicella (MMRV) VIS PDF ([link removed]) (view in English ([link removed]) )
* Meningococcal ACWY VIS PDF ([link removed]) (view in English ([link removed]) )
* Meningococcal B VIS PDF ([link removed]) (view in English ([link removed]) )
* Pneumococcal conjugate (PCV) VIS PDF ([link removed]) (view in English ([link removed]) )
* Polio VIS PDF ([link removed]) (view in English ([link removed]) )
* Rotavirus VIS PDF ([link removed]) (view in English ([link removed]) )
* Tetanus, diphtheria (Td) VIS PDF ([link removed]) (view in English ([link removed]) )
* Tetanus, diphtheria, pertussis (Tdap) VIS PDF ([link removed]) (view in English ([link removed]) )
* Varicella (chickenpox) VIS PDF ([link removed]) (view in English ([link removed]) )
* Recombinant zoster (shingles) VIS PDF ([link removed]) (view in English ([link removed]) )
Translations of previous VIS versions may be used until new translations become available. CDC states that the corresponding up-to-date English-language VIS must also be supplied when providing an out-of-date translation.
Related Links
* Immunize.org: Vaccine Information Statement ([link removed]) main page for VISs in 46 languages ([link removed])
* Immunize.org: Dates of Current Vaccine Information Statements ([link removed]) (PDF)
* CDC: What's New with VISs ([link removed]) web page
* CDC: Current VISs ([link removed]) web page
------------------------------------------------------------
Featured Resources
------------------------------------------------------------
CHOP’s Vaccine Education Center releases “Communicating about Vaccines – COVID-19 and More,” a free, web-based interactive module; CE available
Children’s Hospital of Philadelphia’s (CHOP) Vaccine Education Center (VEC) released Communicating about Vaccines – COVID-19 and More ([link removed]) , a free, web-based interactive session. It is divided into three parts:
* Part 1: Details the dangers of COVID-19 disease, explains the U.S. system to authorize and license vaccines, and highlights the safety and effectiveness of COVID-19 vaccines
* Part 2: Explores best practices in vaccine communication
* Part 3: Reviews key points, offers additional resources, and explains how to receive continuing education credit (up to 2 hours) or a certificate of attendance
To access versions “for credit” (registration required) or “no credit,” visit Online Learning for Healthcare Providers ([link removed]) web page.
[link removed]
This module was developed by the Vaccine Education Center ([link removed]) and the Office of Community Engagement at CHOP, in partnership with the Pennsylvania Chapter of the American Academy of Pediatrics, Pennsylvania Immunization Coalition, and Philadelphia Department of Public Health.
------------------------------------------------------------
Order today! Laminated versions of CDC’s 2022 immunization schedules available while supplies last.
Immunize.org's laminated versions of the 2022 U.S. child and adolescent immunization schedule ([link removed]) and the 2022 U.S. adult immunization schedule ([link removed]) are in stock and shipping now. Order while supplies last.
While the schedules are available online from CDC at no cost, Immunize.org's printed, laminated schedules are ideal for use in any busy healthcare setting where vaccinations are given. Their tough coating can be wiped down, and they’re durable enough to stand up to a year's worth of use.
In 2022, the length of each schedule with appendices was extended by two pages. As a result, the laminated schedules are now published in a standard 8.5” X 11” booklet format.
* The child/adolescent schedule booklet is ten pages (i.e., five double-sided pages) and includes a bonus page with Immunize.org’s popular 1-page handout summarizing the dose, route, and needle size recommendations for all vaccines and recipients
* The adult schedule booklet is eight pages (i.e., four double-sided pages)
[link removed]
With color coding for easy reading, our laminated schedules replicate the original CDC formatting, including the essential tables and notes.
PRICING
Number of Copies Cost
1–4 copies $7.50 each
5–19 copies $5.50 each
20–99 copies $4.50 each
100–499 copies $4.00 each
500–999 copies $3.50 each
For quotes on customizing or placing orders of 1,000 copies or more, call 651-647-9009 or email [email protected].
Visit the Shop Immunize.org: Laminated Schedules ([link removed]) web page for more information on the schedules, to view images of all the pages, to download the order form, and to order today!
Related Links
* Immunize.org: Laminated Child and Adolescent Immunization Schedules (0–18 years) ([link removed]) web page
* Immunize.org: Laminated Adult Immunization Schedules (19 and older) ([link removed]) web page
* Immunize.org: Shop Immunize.org ([link removed]) main page
------------------------------------------------------------
Organizing a new vaccination program? Use Immunize.org’s Vaccinating Adults: A Step-by-Step Guide—free to download by chapter or in its entirety.
Download Immunize.org’s free 142-page book on adult vaccination, to help build your program and train your team: Vaccinating Adults: A Step-by-Step Guide (Guide) ([link removed]) .
[link removed]
This thorough "how to" guide on adult vaccination provides easy-to-use, practical information covering all essential activities. It helps vaccine providers enhance their existing adult vaccination services or introduce them into any clinical setting.
The Guide is available to download/print either by chapter or in its entirety free at www.immunize.org/guide ([link removed]) . The National Vaccine Program Office and CDC both supported the development of the Guide and provided early technical review.
The Guide is a valuable resource to assist providers in increasing adult vaccination rates. Be sure to get a copy today!
Please note: this guide was produced in 2017, before the COVID-19 era, and reflects the recommendations of that time.
Related Links
* Vaccinating Adults: A Step-by-Step Guide ([link removed]) main page, permitting download of entire Guide (142 pages, PDF) ([link removed])
* View the table of contents and individual chapters (PDF):
+ Table of Contents ([link removed])
+ Step 1: Getting Started ([link removed])
+ Step 2: Setting Up for Vaccination Services ([link removed])
+ Step 3: Vaccine Storage and Handling ([link removed])
+ Step 4: Deciding Whom to Vaccinate ([link removed])
+ Step 5: Administering Vaccines ([link removed])
+ Step 6: Documentation and Related Issues ([link removed])
+ Step 7A: Financial Considerations ([link removed])
+ Step 7B: How to Bill for Adult Immunizations ([link removed])
* Immunize.org’s educational materials (handouts) on adult immunization ([link removed])
------------------------------------------------------------
Notable Publications
------------------------------------------------------------
“Effectiveness of COVID-19 mRNA Vaccination in Preventing COVID-19-Associated Hospitalization among Adults with Previous SARS-CoV-2 Infection—United States, June 2021–February 2022” published in MMWR
CDC published Effectiveness of COVID-19 mRNA Vaccination in Preventing COVID-19-Associated Hospitalization among Adults with Previous SARS-CoV-2 Infection—United States, June 2021–February 2022 ([link removed]) in MMWR. A portion of the summary appears below.
Persons with previous SARS-CoV-2 infection have some protection against reinfection leading to hospitalization, but there is limited evidence regarding the additional benefit of vaccination among these persons....
Among persons with previous infection, COVID-19 mRNA vaccination provided protection against subsequent COVID-19–associated hospitalization. Estimated vaccine effectiveness against reinfection leading to hospitalization during the Omicron-predominant period was approximately 35% after dose 2, and 68% after a booster dose....
To prevent COVID-19–associated hospitalization, all eligible persons should stay up to date with vaccination, including those with previous SARS-CoV-2 infection.
Access the MMWR article in HTML ([link removed]) or PDF ([link removed]) .
Related Link
* MMWR's main page ([link removed]) provides access to MMWR Weekly and its companion publications
------------------------------------------------------------
“Supporting Immunization Programs to Address COVID-19 Vaccine Hesitancy: Recommendations for National and Community-Based Stakeholders” published in Vaccine
In its March 28 issue, Vaccine published Supporting Immunization Programs to Address COVID-19 Vaccine Hesitancy: Recommendations for National and Community-Based Stakeholders ([link removed]) . The article is a collaborative effort of the Association of Immunization Managers, with lead author Katelyn Wells, MS, PhD, Immunize.org's Kelly L. Moore, MD, MPH, and Emory University’s Robert Bednarczyk, PhD. The conclusion appears below.
The 64 state, local and territorial IPs [immunization programs] are the backbone of the US immunization system, so we advocate for engagement of all stakeholders to directly support IPs in addressing vaccine hesitancy within their jurisdictions. To maintain routine vaccination coverage rates and implement a successful COVID-19 vaccination campaign, IPs need engagement of stakeholders at all levels to promote sound immunization policies, identify and address the needs of vulnerable subpopulations, implement evidence-based strategies to promote the value of vaccination, and combat misinformation online. IPs, with support of stakeholders, are the key to effectively addressing the complex challenges of vaccine hesitancy in order to bring the pandemic to a swift end.
------------------------------------------------------------
"Become a Vaccine Champion" published by American Federation of Teachers
The American Federation of Teachers published Become a Vaccine Champion ([link removed]) , written by Immunize.org’s Mary Beth Koslap-Petraco, DNP, FAANP. A portion of the article appears below.
By virtue of our profession, nurses have a head start in championing vaccines for ourselves, our patients, and our communities. Ours is the most trusted of all professions. We are rated highly because we’re seen as honest and ethical. The public trusts that we put our patients’ needs ahead of the interests of others. Our voices are heard and our opinions are respected because of what we do. No matter what field of nursing we practice, we all spend much of our time educating patients. We have a way of speaking that makes complicated material understandable without talking down to patients. We need to use that influence to clarify misinformation about vaccines, reassure each other and the public that the science behind vaccines is solid, and encourage everyone to get vaccinated. I truly believe that every nurse should be a vaccine champion and that every nurse can be a vaccine champion. It all starts with conversations with fellow nurses who may be hesitant about vaccines.
------------------------------------------------------------
Global News
------------------------------------------------------------
“Surveillance to Track Progress toward Polio Eradication—Worldwide, 2020–2021” published in MMWR
CDC published Surveillance to Track Progress toward Polio Eradication—Worldwide, 2020–2021 ([link removed]) on April 15 in MMWR. A portion of the summary appears below.
Acute flaccid paralysis (AFP) surveillance, the primary means of tracking poliovirus transmission, is supplemented by environmental surveillance of sewage samples. The COVID-19 pandemic negatively affected polio surveillance....
Analysis of 2020–2021 AFP surveillance data from 43 priority countries experiencing or at high risk for poliovirus transmission found that national AFP surveillance performance improved from 2020 to 2021 in many priority countries, particularly in the World Health Organization’s African Region; however, substantial national and subnational gaps persist....
Surveillance gaps need to be identified and addressed to ensure timely detection of poliovirus circulation and achieve eventual eradication.
Access the MMWR article in HTML ([link removed]) or PDF ([link removed]) .
Related Links
* MMWR's main page ([link removed]) provides access to MMWR Weekly and its companion publications
* Immunize.org: Vaccines: Polio ([link removed]) main page
* Immunize.org: Ask the Experts: Polio ([link removed]) web page
Back to top (#Top)
------------------------------------------------------------
“One-Dose Human Papillomavirus (HPV) Vaccine Offers Solid Protection against Cervical Cancer” published by WHO
The World Health Organization (WHO) published One-Dose Human Papillomavirus (HPV) Vaccine Offers Solid Protection against Cervical Cancer ([link removed]-(hpv)-vaccine-offers-solid-protection-against-cervical-cancer) on April 11. The recommendations of WHO do not alter the ACIP-recommended schedule for HPV vaccination in the United States.
A portion of the article appears below.
The 4-7 April convening of the WHO Strategic Advisory Group of Experts on Immunization (SAGE) evaluated the evidence that has been emerging over past years that single-dose schedules provide comparable efficacy to the two or three-dose regimens.
SAGE’s review concluded that a single-dose Human Papillomavirus (HPV) vaccine delivers solid protection against HPV, the virus that causes cervical cancer, that is comparable to 2-dose schedules. This could be a game-changer for the prevention of the disease; seeing more doses of the life-saving jab reach more girls....
“The HPV vaccine is highly effective for the prevention of HPV serotypes 16 & 18, which cause 70% of cervical cancer,” said Dr Alejandro Cravioto, SAGE Chair. “SAGE urges all countries to introduce HPV vaccines and prioritize multi-age cohort catch up of missed and older cohorts of girls. These recommendations will enable more girls and women to be vaccinated and thus preventing them from having cervical cancer and all its consequences over the course of their lifetimes.”
SAGE recommended one- or two-dose vaccination schedules for girls and women through age 20 and two doses for women 21 and older. WHO’s recommendations will be updated following further consultation across stakeholders.
Related Links
* SAGE: April 4–7, 2022, meeting highlights ([link removed]) (PDF)
* Immunize.org: Vaccines: Human Papillomavirus (HPV) ([link removed]) main page
* Immunize.org: Ask the Experts: HPV ([link removed]) web page
------------------------------------------------------------
Upcoming Events
------------------------------------------------------------
Tomorrow! Virtual: Immunize Colorado hosts webinar “For Mothers, by Mothers: A Community Health Meetup That Supports Vaccine Confidence” on April 21.
Immunize Colorado ([link removed]) will host a webinar with IDEO.org ([link removed]) and National Resource Center for Refugees, Immigrants, and Migrants ([link removed]) (NRC-RIM) titled For Mothers, by Mothers: A Community Health Meetup That Supports Vaccine Confidence ([link removed]) at 12:00 p.m. (ET) on April 21. The webinar showcases the Mothers X Mothers ([link removed]) initiative, a toolkit designed to help organizations implement health-focused meetups for immigrant and refugee moms. There will also be focus on how organizations can support vaccine confidence in any community.
Register for the webinar ([link removed]) .
This event will be archived on Immunize Colorado's Education Series Past Events ([link removed]) web page.
------------------------------------------------------------
Virtual: International Vaccine Access Center hosts webinars on April 26, 28, and May 3 for World Immunization Week
Johns Hopkins University's International Vaccine Access Center ([link removed]) (IVAC), along with global immunization and indigenous health partners, will host a series of three webinars ([link removed]) to recognize World Immunization Week, April 24 to 30. Registration dates and times are as follows:
* April 26 from 6:00–7:00 p.m. (ET): Enabling Equitable Access to COVID-19 Vaccines for Indigenous Populations ([link removed])
* April 28 from 8:00–9:00 a.m. (ET): The Value of Vaccines across the Life Course: A Showcase of Global Findings ([link removed])
* May 3 from 9:00–10:30 a.m. (ET): The Human Cost of Pneumonia and the Power of the PCV: Stories from Somalia and India ([link removed])
The webinars are free to attend.
------------------------------------------------------------
In person: Register today! National Conference for Immunization Coalitions and Partnerships to be held September 13–15, 2022, in Minneapolis, MN.
Immunize.org and Voices for Vaccines are cosponsoring the 15th National for Immunization Coalitions and Partnerships ([link removed]) (NCICP). This is planned as an in-person meeting in Minneapolis/St. Paul at the Radisson Blu Mall of America ([link removed]) on September 13–15, 2022.
[link removed]
The NCICP is the only conference solely dedicated to collaboration and partnership to improve immunization uptake, educate our communities, and prevent the spread of disease. The conference is an engine to address immunizations and public health challenges by sharing successful strategies that strengthen the work our coalitions and partnerships do.
Register for the event ([link removed]) . Registration fee: $300 (early bird $260 registration available now).
------------------------------------------------------------
For more upcoming events, visit our Calendar of Events ([link removed]) .
Editorial Information
Editor-in-Chief
Kelly L. Moore, MD, MPH
Managing Editor
John D. Grabenstein, RPh, PhD
Associate Editor
Sharon G. Humiston, MD, MPH
Writer/Publication Coordinator
Taryn Chapman, MS
Courtnay Londo, MA
Style and Copy Editor
Marian Deegan, JD
Web Edition Managers
Arkady Shakhnovich
Jermaine Royes
Contributing Writer
Laurel H. Wood, MPA
Technical Reviewer
Robin VanOss
About IZ Express
Immunize.org welcomes redistribution of this issue of IZ Express or selected articles.
When you do so, please add a note that Immunize.org is the source of the material and provide a link to this issue ([link removed] ) .
IZ Express is supported in part by Grant No. 1NH23IP922654 from the National Center for Immunization and Respiratory Diseases, CDC. Its contents are solely the responsibility of Immunize.org and do not necessarily represent the official views of CDC.
IZ Express Disclaimer ([link removed])
ISSN: 2771-8085
==============================================
Unsubscribe [email protected] from this list:
[link removed]
Message Analysis
- Sender: Immunization Action Coalition
- Political Party: n/a
- Country: United States
- State/Locality: n/a
- Office: n/a
-
Email Providers:
- MailChimp